SCHEMBL1109730

SCHEMBL1109730

C1=C(C2=CCCCC2)CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMP P19971 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
ACMSD Q8TDX5 2/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37
KDM1A O60341 1/20 0.37
PSMB5 P28074 4/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
PTGS2 P35354 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
PSMB1 P20618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960583 0.97 TYMP (0.39) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL296554 0.97 TYMP (0.42) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL18244172 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL2105114 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL3796623 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL3233362 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL3502363 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL18244171 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL21057468 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD
SCHEMBL11201526 0.93 TYMP (0.41) TYMPTDP1ALDH1A1CYP3A4ACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105777558-A Compound, organic light-emitting device including the same, and flat-panel display 三星显示有限公司 2016-07-20 CN claimed
US-6080763-A INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES, E.G., TUMOR NECROSIS FACTOR AND INTERLEUKIN-1; USEFUL TO TREAT CHRONIC INFLAMMATORY DISEASE; AUTOIMMUNE DISEASES, E.G. RHEUMATOID ARTHRITIS, OSTEOPOROSIS; PYRAZOLYLUREAS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-06-27 US claimed
US-20240059681-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF HAISCO PHARMACEUTICALS PTE. LTD. (SG) 2024-02-22 US disclosed
CN-113045828-B Selective laser sintering composition and three-dimensional printing method using the same 财团法人工业技术研究院 2024-01-26 CN disclosed
US-20230167545-A1 STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C2H2 LAM RESEARCH CORPORATION 2023-06-01 US disclosed
EP-4118064-A1 <SUP2/>? <SUB2/>?2?STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE CH <NS1:SUB>2</NS1:SUB> Lam Research Corporation (US) 2023-01-18 EP disclosed
WO-2021183922-A1 STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C2H2 LAM RESEARCH CORPORATION (US) 2021-09-16 WO disclosed
WO-2021059017-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-04-01 WO disclosed
CN-111732499-A Process for producing cycloalkylalkyl ether compound 日本瑞翁株式会社 2020-10-02 CN disclosed
CN-105431149-B Neuroprotective multifunctional antioxidants and their monofunctional analogs 彼得·F·卡罗 2019-06-11 CN disclosed
EP-2956140-B1 NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS KADOR PETER F (US) 2018-07-11 EP disclosed
EP-0362814-B1 Ethylene/polycyclic monomer copolymer, process for preparation thereof, and optical article SHOWA DENKO KK (JP) 1995-08-16 EP disclosed
EP-0251164-B1 NEW CHIRAL PHOSPHINOPYRROLIDINE COMPOUNDS AND THEIR USE FOR ASYMETRIC SYNTHESIS OF OPTICALLY ACTIVE COMPOUNDS Achiwa, Kazuo (JP) 1992-12-16 EP disclosed
US-5075384-A Air-drying, curable protective coatings comprising an allyl alcohol-styrene copolymer carbamylated by an unsaturated isocyanate, an acrylic monomer and an allyl monomer; gloss; toughness MONSANTO (US) 1991-12-24 US disclosed
US-5049633-A Ethylene/polycyclic monomer copolymer, process for preparation thereof, and optical article SHOWA DENKO K.K. (JP) 1991-09-17 US disclosed
US-5030696-A Air- or heat-curable protective coatings of unsaturated isocyanate-modified styrene-allyl alcohol copolymer, an acrylic compound and an allyl compound; furniture; toughness MONSANTO COMPANY (US) 1991-07-09 US disclosed
US-5026771-A Coating compositions containing ethylenically unsaturated carbamates MONSANTO COMPANY (US) 1991-06-25 US disclosed
EP-0362814-A2 Ethylene/polycyclic monomer copolymer, process for preparation thereof, and optical article SHOWA DENKO KABUSHIKI KAISHA (JP) 1990-04-11 EP disclosed
EP-0251164-A2 New chiral phosphinopyrrolidine compounds and their use for asymetric synthesis of optically active compounds Achiwa, Kazuo (JP) 1988-01-07 EP disclosed
US-4216232-A Pharmaceutical compositions BEECHAM GROUP LIMITED (GB) 1980-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059681-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF DPP4, DPP3, DPP9 TYMP 4172/4885TDP1 747/4885ALDH1A1 1267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.